ライフサイエンスコーパス: pharmaceutical agent

1 ated on both a complex natural product and a pharmaceutical agent.

2 st in developing equol as a nutraceutical or pharmaceutical agent.

3 s of sucrose octasulfate (SOS), an important pharmaceutical agent.

4 heterocycles, as well as aromatic-containing pharmaceutical agents.

5 responses to physiological stimuli or indeed pharmaceutical agents.

6 eins, serving as targets for the majority of pharmaceutical agents.

7 e useful in the development of antimicrobial pharmaceutical agents.

8 nalogues of these compounds may be useful as pharmaceutical agents.

9 ular target for the development of antiviral pharmaceutical agents.

10 to the development of new immunosuppressive pharmaceutical agents.

11 n constants, and have been targeted as novel pharmaceutical agents.

12 acellular delivery of a variety of molecular/pharmaceutical agents.

13 reactions are a mainstay in the synthesis of pharmaceutical agents.

14 C-H bonds are present in almost all pharmaceutical agents.

15 y found in biologically active compounds and pharmaceutical agents.

16 found in many secondary metabolites and some pharmaceutical agents.

17 tant molecules, including polymers, dyes and pharmaceutical agents.

18 are particularly important features of many pharmaceutical agents.

19 that involve tea as well as other dietary or pharmaceutical agents.

20 oactive molecules, including amino acids and pharmaceutical agents.

21 le can be further extended to other toxic or pharmaceutical agents.

22 es, are widely used as antibiotics and other pharmaceutical agents.

23 ct trifluoromethylation of widely prescribed pharmaceutical agents.

24 challenges associated with the design of new pharmaceutical agents.

25 ul in the delivery and controlled release of pharmaceutical agents.

26 HSCT recipient beyond limitations of current pharmaceutical agents.

27 t a robust protocol for fingerprinting these pharmaceutical agents.

28 is of complex natural products and potential pharmaceutical agents.

29 ent I(Kr), is the unintended target for many pharmaceutical agents.

30 aving the potential of being highly specific pharmaceutical agents.

31 comparable with those used in regulating new pharmaceutical agents.

32 ntrast media (ICM) are commonly administered pharmaceutical agents.

33 lves as leads in the identification of novel pharmaceutical agents.

34 e-activity relations for this novel class of pharmaceutical agents.

35 5 mo while treating them with a vehicle or a pharmaceutical agent (4MDM) that selectively augments th

36 s research contributes to the development of pharmaceutical agents against endotoxemia and septic sho

37 pt profile was distinctly different for each pharmaceutical agent and that raloxifene maintained more

38 idines are prevalent in natural products and pharmaceutical agents and are important synthetic target

39 ent method for assessing the impact of novel pharmaceutical agents and clinical management protocols.

40 d) are important structural elements in many pharmaceutical agents and natural products.

41 the brain change itself, sometimes aided by pharmaceutical agents and other treatments.

42 portance of these compounds as components in pharmaceutical agents and peptidomimetics.

43 The active release of pharmaceutical agents and the use of porous sensor membr

44 e high-throughput toxicological screening of pharmaceutical agents and treatment regimens on organoty

45 nature, and also provide core scaffolds for pharmaceutical agents and vaccines.

46 ole in the evaluation and development of new pharmaceutical agents and will be increasingly used in c

47 verse effects of abused psychostimulants and pharmaceutical agents, and can be adapted for use in neu

48 and are commonly found in natural products, pharmaceutical agents, and materials.

49 sence in a wide variety of natural products, pharmaceutical agents, and mimics of protein structural

50 ons of DNA and RNA with regulatory proteins, pharmaceutical agents, and other ligands.

51 n an array of bioactive natural products and pharmaceutical agents are often synthesized by asymmetri

52 as stenting, photodynamic therapy, and novel pharmaceutical agents are under consideration as methods

53 With pharmaceutical agents as functional anions ([RdrugOPO3](

54 , enantioselective synthesis of an important pharmaceutical agent, atomoxetine.

55 at may be inhibited by structurally distinct pharmaceutical agents both in vitro and in vivo.

56 egies, such as self-help, counseling, single pharmaceutical agents, combined pharmacotherapies, and p

57 Notably, structurally complex pharmaceutical agents could be functionalized or prepare

58 tory effects on one another, suggesting that pharmaceutical agents designed to inhibit NOS2 or COX-2

59 pecifically, and novel techniques to deliver pharmaceutical agents directly to HSC, potentially allow

60 production errors, or by contamination with pharmaceutical agents, either as a result of poor manufa

61 erse range of reports from this field aim at pharmaceutical agent encapsulation, targeted drug-delive

62 ducts in good yields (75-99%), including the pharmaceutical agents fenpiprane and prozapine.

63 allenges not shared in the usual paradigm of pharmaceutical agents for prevention of cardiovascular d

64 bute to the development of a novel family of pharmaceutical agents for the improvement of the healing

65 rtant carbon-containing molecules, including pharmaceutical agents, fragrances and polymers.

66 ew US Food and Drugs Administration approved pharmaceutical agents further eliminate testosterone lig

67 r the completion of treatment during which a pharmaceutical agent has maximum access to high-grade gl

68 Induction of cell differentiation using pharmaceutical agents has been clinically attempted for

69 A variety of pharmaceutical agents has been proposed for use in perio

70 No effective pharmaceutical agents have yet been identified to treat

71 rophenol and resorcinol) and a few important pharmaceutical agents (i.e., hexobarbital, oxazepam, and

72 Of the pharmaceutical agents identified, there was enrichment f

73 Therefore, 4SC-101 might be a promising pharmaceutical agent in Tx medicine for further investig

74 re increasingly being developed as potential pharmaceutical agents in targeting metalloenzymes.

75 le as well as provide benefit beyond that of pharmaceutical agents in treating heart disease.

76 We review available articles characterizing pharmaceutical agents including alpha receptor antagonis

77 ne and the formal synthesis of several other pharmaceutical agents, including duloxetine, atomoxetine

78 eaction should be applicable to a variety of pharmaceutical agents, including NO synthase inhibitors,

79 ction in nanoscale drug delivery systems for pharmaceutical agents, including small molecules, protei

80 When a pharmaceutical agent is encapsulated within, or attached

81 ips with constituent biological entities and pharmaceutical agents is crucial for drug design and dis

82 To fully develop their potential as pharmaceutical agents it is necessary to understand both

83 Furthermore, new pharmaceutical agents moderating the intracellular and e

84 rous interesting molecules such as peptides, pharmaceutical agents, naturally occurring molecules, pr

85 Ajmaline is a pharmaceutical agent now administered globally for a var

86 A variety of these biologic and pharmaceutical agents offer promise as potential therapi

87 Thus, pHLIP could be used for delivery of pharmaceutical agents or imaging probes to the myocardia

88 in ill-defined and there are no FDA approved pharmaceutical agents or medical countermeasures.

89 l products have led to the discovery of many pharmaceutical agents, particularly antibiotics.

90 rough one-step syntheses of two high-profile pharmaceutical agents, Plavix and amfepramone.

91 eukotriene A4 aminopeptidase activity with a pharmaceutical agent protected murine lungs from develop

92 concentrations similar to those achieved by pharmaceutical agents, remarkably little is known about

93 rbon-monoxide-releasing molecules (CORMs) as pharmaceutical agents represents an attractive and safer

94 useful with respect to in vivo monitoring of pharmaceutical agents selected for their ability to prev

95 Pharmaceutical agents such as valproate, which counterac

96 Although pharmaceutical agents targeting multiple biological path

97 s in the preclinical evaluation of candidate pharmaceutical agents targeting protein-protein interact

98 e avoided with the use of existing and novel pharmaceutical agents targeting specific inflammatory me

99 A range of novel pharmaceutical agents that aim to target liposarcoma-spe

100 Pharmaceutical agents that could suppress the induced ex

101 We report the identification of pharmaceutical agents that enhance VH and use these agen

102 Treatment with pharmaceutical agents that regulate or are metabolized b

103 ionale for the 10-mer and its derivatives as pharmaceutical agents that target specific cell growth.

104 n relationships and to improve the design of pharmaceutical agents that target specific RNA motifs, a

105 r of derivatives of 1 are being developed as pharmaceutical agents, the similarity of the chemistry o

106 proteins have been increasingly important as pharmaceutical agents, their chemical and physical insta

107 ugh naked antibodies have proven valuable as pharmaceutical agents, they have some limitations, such

108 nately, the use of brain-derived peptides as pharmaceutical agents to alter brain chemistry in vivo h

109 studies conducted to investigate the use of pharmaceutical agents to retard or cure the loss of cone

110 Transduction can be enhanced by pharmaceutical agents up to sevenfold in primary cells (

111 Dipyridamole, a pharmaceutical agent used for the first time as a fluore

112 Unlike many of the pharmaceutical agents used in patients with coronary art

113 rementioned parameters and on consumption of pharmaceutical agents was assessed.

114 ocycles in biologically active alkaloids and pharmaceutical agents, we envisage that our method will

115 glumine, an MR-detectable model representing pharmaceutical agents, were then injected intravenously.

116 Pharmaceutical agents which would prevent the induced ex

117 environment interactions, and they serve as pharmaceutical agents with antimicrobial and anti-tumor

118 al is made for physicians to prescribe those pharmaceutical agents with definitive evidence of mortal

119 duced by curcumin can potentially lead to AD pharmaceutical agents with inherent bio-compatibility.

120 ound targeted the delivery of macromolecular pharmaceutical agents within tissues.